Clinical Trial Update: A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing olmesartan medoxomil to placebo in patients with established atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Atherosclerosis | Phase 3 | Status: COMPLETED